Company: GEHC
Filing Date: 2025-06-05
Form Type: 424B2
Source: 0001193125-25-135863
Chunk: 9

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-06-05
Form: 424B2
Chunk 9
---
 secured indebtedness. These restrictions are subject to a number of 
 exceptions. See “Description of Notes.”                                                                                                                                                                                                      |

| Form and Denomination | The notes will be issued in fully registered form in denominations of $2,000 and in integral multiples of $1,000 in excess thereof. |

| DTC Eligibility | The notes will be represented by global certificates deposited with, or on behalf of, DTC, including its participants Clearstream and Euroclear, or their nominees. See “Book-Entry; Delivery and Form.” |

| No Trading Market | The notes constitute a new issue of securities, for which there is no existing trading market. In addition, we do not intend to apply to list any of the notes on any securities exchange or for quotation on any automated quotation system. We         
 cannot provide you with any assurance regarding whether trading markets for the notes will develop, the ability of holders of the notes to sell their notes or the prices at which holders may be able to sell their notes. If no active trading markets 
 develop, you may be unable to resell the notes at any price or at their fair market value or at all.                                                                                                                                                     |

| Use of Proceeds | We estimate that the net proceeds to us from this offering will be approximately $1,487 million, after deducting the underwriting discounts and estimated offering expenses payable by us. We expect to use the net proceeds from this offering,  
 together with cash on hand, to repay the $1,500 million aggregate principal amount outstanding of the 2025 notes, and pay accrued interest, related premiums, fees and expenses in connection therewith. Pending the final application of the net 
 proceeds of this offering, we may use such proceeds temporarily for general corporate purposes. See “Use of Proceeds.” Certain of the underwriters or their affiliates may hold some of the 2025 notes being repaid and, accordingly, may         
 receive a portion of the net proceeds of this offering. See “Underwriting.”                                                                                                                                                                       |

| Additional Issuances | We may from time to time, without notice to or the consent of the holders of the notes, create and issue additional notes of any series ranking equally                                                                                           
 and ratably with the notes of such series in all respects, or in all respects except for the payment of interest accruing prior to the issue date or except for the first payment of interest following the issue date of those additional notes; 
 provided that, if such additional notes of the applicable series are not fungible for U.S